Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)

NCT01627288 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01627288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01627288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
June 4, 2012
Completion date
November 16, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the cervix, cervical neoplasms